However, the inhibition of GSK-3β alone could not activate the Wnt pathway [14], while inhibition of P53 could only partially restore the osteogenic ability of BMSCs in patients with type 2 diabetes [15]. The gene discussed is TP53; the disease is type 2 diabetes mellitus.